PLUS1
2.94
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eyenovia Inc | EYEN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.07 | 2.44% | 2.94 | 2.75 | 2.99 | 2.87 | 2.87 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.75 | 5.00 | 2.25 | 45.0% | 1 | 1 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 207 | 55,755 | $ 2.85 | $ 158,849 | 39,707 | 1.11 - 5.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 409 | $ 2.94 | USD |
Eyenovia Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 58.14M | 19.78M | 12.95M | $ - | $ - | -1.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 6.00 | 11.40% |
Eyenovia News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/05/2020 | 16:19 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) |
| 6/05/2020 | 16:10 | GlobeNewswire Inc. | Eyenovia Announces Intention to Adjourn 2020 Annual Meeting.. |
| 5/14/2020 | 13:11 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 5/13/2020 | 16:22 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) |
| 5/13/2020 | 16:14 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 5/13/2020 | 16:05 | GlobeNewswire Inc. | Eyenovia Reports First Quarter 2020 Financial Results |
| 5/08/2020 | 16:33 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3/a) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EYEN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.90 | 2.99 | 2.70 | 2.83 | 35,953 | 0.04 | 1.38% |
| 1 Month | 3.61 | 4.11 | 2.70 | 3.12 | 46,637 | -0.67 | -18.56% |
| 3 Months | 2.27 | 4.11 | 1.11 | 2.84 | 44,358 | 0.67 | 29.52% |
| 6 Months | 3.54 | 5.00 | 1.11 | 3.48 | 56,000 | -0.60 | -16.95% |
| 1 Year | 5.00 | 5.50 | 1.11 | 3.42 | 80,187 | -2.06 | -41.2% |
| 3 Years | 10.00 | 10.74 | 1.11 | 4.24 | 78,209 | -7.06 | -70.6% |
| 5 Years | 10.00 | 10.74 | 1.11 | 4.24 | 78,209 | -7.06 | -70.6% |
Eyenovia Description
| Eyenovia Inc is a clinical-stage biopharmaceutical company operating in the US. It is engaged in developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver micro-therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. The pipeline products of the company are MicroProst for chronic angle closure glaucoma, MicroStat for pharmacologic mydriasis, MicroTears for dry eye and MicroPine for myopia. |
